Cash from Financing (Quarterly) Chart

Historical Cash from Financing (Quarterly) Data

View and export this data back to 1998. Start Trial.
Date Value
June 30, 2026 0.948M
March 31, 2026 -6.289M
December 31, 2025 5.062M
September 30, 2025 -0.365M
June 30, 2025 4.347M
March 31, 2025 6.955M
December 31, 2024 2.432M
September 30, 2024 -47.57M
June 30, 2024 3.137M
March 31, 2024 -18.00M
December 31, 2023 472.81M
September 30, 2023 -54.55M
June 30, 2023 141.51M
March 31, 2023 -0.497M
December 31, 2022 -5.749M
September 30, 2022 -27.07M
June 30, 2022 -13.20M
March 31, 2022 -14.24M
December 31, 2021 -32.47M
September 30, 2021 -17.89M
June 30, 2021 -21.83M
March 31, 2021 -26.25M
December 31, 2020 -4.548M
September 30, 2020 -51.98M
June 30, 2020 -32.95M
Date Value
March 31, 2020 -6.234M
December 31, 2019 -0.167M
September 30, 2019 25.94M
June 30, 2019 17.58M
March 31, 2019 -9.821M
December 31, 2018 187.92M
September 30, 2018 2.239M
June 30, 2018 28.62M
March 31, 2018 109.50M
December 31, 2017 0.809M
September 30, 2017 38.06M
June 30, 2017 6.923M
March 31, 2017 50.72M
December 31, 2016 -2.441M
September 30, 2016 98.82M
June 30, 2016 3.526M
March 31, 2016 21.20M
December 31, 2015 -2.747M
September 30, 2015 1.504M
June 30, 2015 -1.715M
March 31, 2015 -7.277M
December 31, 2014 -11.76M
September 30, 2014 -8.238M
June 30, 2014 -3.287M
March 31, 2014 6.314M

Cash From Financing Definition

Represents the net cash flow resulting from the company's financing activities. Financing activities represent movement in the company's debt and share capital and other activities.

Read full definition.

Cash from Financing (Quarterly) Range, Past 5 Years

View Cash from Financing (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Financing (Quarterly) Benchmarks

View Cash from Financing (Quarterly) Benchmarks
Start Trial
Globus Medical, Inc. -134.50M
Baxter International, Inc. -31.00M
DexCom, Inc. -607.30M
Haemonetics Corp. -51.53M
ICU Medical, Inc. -50.24M